An agreement has been reached between BioNTech and Bristol Myers Squibb for the worldwide co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across a variety of solid tumor types.
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price ceilings on 41 combinations of drugs, including 18 types of Boehringer Ingelheim's
The Authentication Solution Providers’ Association (ASPA) ahead of World Anti-Counterfeiting Day, has commissioned the second edition of its flagship industry report, ‘State of Counterfeiting in India – 2025
Allarity Therapeutics, a Phase 2-stage biopharmaceutical with activities in Copenhagen and Boston, has formally enrolled its first patient in its newly launched Phase 2 trial
Aumolertinib (Aumseqa) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for adult patients with non-small cell lung cancer (NSCLC).
Gland Pharma Limited saw its shares rise nearly 3% during intraday trading on Wednesday following the announcement of a major regulatory accomplishment...
Reckitt, the world's leading consumer health and hygiene company, associated with the Public Health Foundation of India
A step in the direction of streamlining and simplification of the export procedure for India's traditional medicinal industry, the Ministry of Commerce and Industry
India is about to give a significant boost to its production-linked incentive (PLI) scheme for pharmaceuticals as it seeks to establish a stronger domestic production of key starting materials (KSMs)...
Zydus Lifesciences is entering the global biologics contract development and manufacturing (CDMO) arena with its acquisition of two biologics facilities from Agenus at Emeryville and Berkeley in California...